EXACT Sciences Corporation (NASDAQ: EXAS) shares spiked 34 percent on June 14, following a JAMA [The Journal of the American Medical Association] article meant for release on June 21 being leaked. BTIG’s Sean Lavin maintained a Buy rating for the company, with a price target of $9. The analyst believes that the shares could move higher as more investors discover the article.
If the JAMA article is published and reflects updated recommendations of the USPSTF [US Preventive Services Task Force], the guidelines would help EXACT Sciences obtain routine reimbursement faster than the company may have under the previous recommendation. “While the update is not a perfect result, we see it as a major positive for the company,” analyst Sean Lavin wrote.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
New Guidelines
The older USPSTF recommendation was less positive and resulted in shares declining from ~$18 to below $10. Although the USPSTF is yet to issue a formal recommendation, the leaked JAMA article states that the USPSTF highly recommends colon cancer screening between ages 50 and 75, but would no longer rank tests; instead, provide a list of acceptable ones that includes FITDNA, or Cologuard.
“While this seems like a bailout by the Task Force and we wonder why it is so reluctant to strongly recommend other tests vs. colonoscopy (relationships would not stun us), we believe being put on par with colonoscopy will help EXAS gain routine reimbursement and more rapid adoption,” Lavin commented.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.